# Vir Biotechnology, Inc.: Form 8-K, filed Mar 2, 2026

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: 8-K
- Filed: 2026-03-02
- Accepted by EDGAR: Mar 2, 2026, 09:01 ET
- Period: 2026-02-26
- Accession: 0001193125-26-084367
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000119312526084367/d50465d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000119312526084367/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000119312526084367/d50465d8k.htm

Filed Mar 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-084367. Last ingested by Listed: Nov 4, 2026, 19:18 ET. No prices; not investment advice.